Incubation Platform

Our incubation platform provides wrap-around shared professional services support, professional network, capital and other entrepreneurial amenities to the companies resident in our Operations and Investments portfolios. Our goal is to help operators, partners and innovators by removing barriers to sustainable growth and unlocking innovation through our global network of research and development domain experts. Areas of interest for our incubation platform include: Drug Discovery technologies utilizing machine learning-enabled, fit-for-purpose chemical and biologics design seeking new molecular targets; Stem-cell and Immune-cell therapies, including indication expansion of chimeric antigen receptor (CAR) T-cell therapies within hematological malignancies; Gene and Oligonucleotide Therapies in clinical development; and Engineered macrophages and regulatory T cells that may reverse the immune drivers of diseases.